Publication date context: 2026 02 15. This report summarizes a completed trial comparing multimodal physiotherapy to an occlusal splint for adults with temporomandibular disorders. Stakeholders in clinical decision making and regulatory affairs should note the status and potential implications.
Meta description: A completed trial comparing multimodal physiotherapy to an occlusal splint for temporomandibular disorders informs regulatory and clinical decision making.
What is studied?
In adults with temporomandibular disorders the trial records the condition as TMD. The two interventions are described as behavioral multimodal physiotherapy and a device described as an occlusal splint. The record indicates the study is completed and the data may be under analysis or awaiting dissemination. The sponsor is listed as Egas Moniz Cooperativa de Ensino Superior CRL. A link to the study page on ClinicalTrials.gov is provided in the source.
What are the arms in the study?
The study centers on two arms. The first uses a behavioral multimodal physiotherapy approach. The second uses an occlusal splint, a device used in dental practice for temporomandibular disorders. The aim is to compare these approaches in adults under the same study framework.
External link: ClinicalTrials.gov record for NCT07410091 at https://clinicaltrials.gov/study/NCT07410091?term=medical+device
Who is behind the study and why it matters?
The sponsor listed for this trial is Egas Moniz Cooperativa de Ensino Superior CRL. The listing suggests an academic or cooperative teaching institution involvement in a device related clinical evaluation. The trial is registered on ClinicalTrials.gov with identifier NCT07410091, and the stated interventions include a device and a behavioral therapy approach. In regulatory terms, such trials contribute to the body of evidence that may inform future device development decisions and regulatory discussions if results are favorable or show safety concerns.
Why does this matter for regulation?
Even when results are not yet public, the existence of a completed trial demonstrates the ongoing collection of real world like data on an occlusal splint as a device and on physiotherapy as a comparator. Regulators may monitor such trials for safety and performance signals that affect future submissions or labeling considerations.
What interventions are being compared?
The trial compares a behavioral multimodal physiotherapy program with an occlusal splint device. The first is described as a behavioral therapy regimen that combines several physiotherapy modalities. The second is a dental device intended to modify occlusion and reduce symptoms in temporomandibular disorders. The source text confirms these are the two arms and notes the study status as completed.
What should be known about the arms?
No efficacy results are provided in the source text. Readers should expect that results, when released, would be essential to interpret the relative value of the two approaches for adults with TMD.
Current status and expected next steps
According to the source, the trial status is completed. The record provides the condition, interventions, sponsor, and the ClinicalTrials.gov identifier but does not include published results in the given extract. The time stamp on the source indicates the update occurred on 2026 02 15 as part of a public data record. The next steps would typically include publication of results or posting of data summaries, which could influence clinical practice and device regulatory considerations.
What are the regulatory implications for devices in this context?
For devices used in temporomandibular disorders, trial results that compare a device to a therapeutic modality can affect evidence requirements for approvals, label claims and post market surveillance. The current record documents the two arms and the existence of a completed study but does not present results. Regulators and industry stakeholders will watch for published outcomes to guide risk benefit assessments and potential labeling updates for occlusal splints as medical devices used in TMD care.
Conclusion and actions for readers
The completed status of the trial NCT07410091 shows ongoing evidence generation for temporomandibular disorder treatments. Regulatory teams should monitor for results and for future publications from the sponsor. Clinicians may anticipate data that could influence practice patterns depending on the outcomes. Device developers may use this record to plan future trials or to align with regulatory expectations for evidence generation in TMD care.
Disclaimer for professionals
This article is intended for professional audiences and does not constitute legal advice. It summarizes a trial record and does not provide medical or regulatory recommendations. For formal guidance please consult regulatory authorities and the trial sponsor s disclosures.
https://clinicaltrials.gov/study/NCT07410091?term=medical+device